Results 141 to 150 of about 35,117 (307)

Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy

open access: yesSupportive Care in Cancer, 2019
N. Mahendraratnam   +5 more
semanticscholar   +1 more source

5‐HT3 receptor antagonists for preventing postoperative nausea and vomiting after gynecological surgery: A systematic review and network meta‐analysis

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 1, Page 177-189, October 2025.
Abstract Background Gynecological surgery is generally associated with a high risk of postoperative nausea and vomiting (PONV), for which a combination of antiemetic therapies is advised, but adherence to these protocols is often low. Given the current reality, a preferred 5‐HT3 receptor antagonist for preventing PONV as a result of gynecological ...
Hongxia Xu   +7 more
wiley   +1 more source

Chemotherapy-Induced Nausea and Vomiting: The Role of Aprepitant

open access: yesMiddle East Journal of Cancer, 2011
Antiemetics are given to cancer patients prior to their chemotherapy sessions to protect them from nausea and vomiting induced by chemotherapy. The responsible health care team member will choose the type of antiemetic required to prevent the patient ...
Muath Mohammed Abu Hilal
doaj  

Cancer in pregnancy: FIGO Best practice advice and narrative review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 1, Page 131-151, October 2025.
Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda   +29 more
wiley   +1 more source

The Pharmacist's Role in the Use of Incretin‐Based Therapies for Weight Management: An Opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 8, Issue 10, Page 1078-1093, October 2025.
ABSTRACT The popularity of incretin‐based therapies has increased substantially over the past several years due to their clinically significant efficacy for weight loss and positive impact on weight‐related comorbid conditions, yet, few clinical practice guidelines for the management of overweight and obesity have been updated to incorporate these ...
Sara Lingow   +6 more
wiley   +1 more source

Cost-effectiveness of Prophylactic Antiemetic Therapy with Ondansetron, Droperidol, or Placebo [PDF]

open access: bronze, 2000
Robert P. Hill   +6 more
openalex   +1 more source

Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

open access: yesCochrane Database of Systematic Reviews, 2016
R. Phillips   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy